Literature DB >> 20858717

E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma.

Céline Greco1, Marie-Pierre Bralet, Naouel Ailane, Anne Dubart-Kupperschmitt, Eric Rubinstein, François Le Naour, Claude Boucheix.   

Abstract

Tumor invasion and metastasis are major obstacles to clinical treatment that rely on cell migration. Here, we elucidate a mechanism of colon carcinoma cell migration that is supported by the cell surface tetraspanin Co-029 (tspan8), which is known to favor tumor progression and metastasis. This mechanism is unmasked by silencing of E-cadherin or its associated adapter molecule p120-catenin (p120ctn), and it involves a switch in signaling between the collagen-binding integrins α(1)β(1) and α(2)β(1). Direct interaction between E-cadherin and Co-029 was documented by chemical cross-linking and immunohistologic analysis of colon carcinomas. High expression of Co-029 and cytoplasmic delocalization of p120ctn were each associated with poor prognosis. Cell motility was reduced severely by antibody-mediated disruption of Co-029 only when p120ctn was silenced, suggesting that tumor progression may be hindered by Co-029 targeting. Our findings define a function for tetraspanin Co-029 as a modifier of cancer cell motility and reveal an adhesion signaling network implicated in progression and metastasis.
© 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858717     DOI: 10.1158/0008-5472.CAN-09-4482

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

Review 1.  Tetraspanins in cell migration.

Authors:  Xupin Jiang; Jiaping Zhang; Yuesheng Huang
Journal:  Cell Adh Migr       Date:  2015-06-19       Impact factor: 3.405

2.  Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

Authors:  Manale El Kharbili; Gweltaz Agaësse; Laetitia Barbollat-Boutrand; Roxane M Pommier; Arnaud de la Fouchardière; Lionel Larue; Julie Caramel; Alain Puisieux; Odile Berthier-Vergnes; Ingrid Masse
Journal:  Oncogene       Date:  2019-01-24       Impact factor: 9.867

Review 3.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.

Authors:  Yonghong Sun; Yahong Xu; Jie Xu; Dan Lu; Jianyu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials.

Authors:  Junxia Chen; Xi Ou-Yang; Juan Gao; Jun Zhu; Xiaoyan He; Jiang Rong
Journal:  Mol Cell Biochem       Date:  2010-12-02       Impact factor: 3.396

6.  Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies.

Authors:  Iona Cheng; Christian P Caberto; Annette Lum-Jones; Ann Seifried; Lynne R Wilkens; Fredrick R Schumacher; Kristine R Monroe; Unhee Lim; Maarit Tiirikainen; Laurence N Kolonel; Brian E Henderson; Daniel O Stram; Christopher A Haiman; Loïc Le Marchand
Journal:  Gut       Date:  2011-05-20       Impact factor: 23.059

7.  Tetraspanin18 is a FoxD3-responsive antagonist of cranial neural crest epithelial-to-mesenchymal transition that maintains cadherin-6B protein.

Authors:  Corinne L Fairchild; Laura S Gammill
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

Review 8.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  TSPAN8 promotes gastric cancer growth and metastasis via ERK MAPK pathway.

Authors:  Lunshou Wei; Yan Li; Zhimin Suo
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.

Authors:  Meenakshi Bhansali; Jun Zhou; Lirim Shemshedini
Journal:  Mol Endocrinol       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.